Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William H Bisson

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Current Topics in Medicinal Chemistry|August 26, 2015
Histone and Non-Histone Targets of Dietary Deacetylase InhibitorsEunah Kim, William H Bisson, Christiane V Löhr, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 17, 2025
Rethinking the Microenvironment's Role in Chemical-Induced MalignancyWilliam H Bisson, Richard A Currie, Emilia L Lim, et al.
Plos One|January 14, 2012
AHR2 mutant reveals functional diversity of aryl hydrocarbon receptors in zebrafishBritton C Goodale, Jane K La Du, William H Bisson, et al.
Biology|October 21, 2014
A Structural Switch between Agonist and Antagonist Bound Conformations for a Ligand-Optimized Model of the Human Aryl Hydrocarbon Receptor Ligand Binding DomainArden Perkins, Jessica L Phillips, Nancy I Kerkvliet, et al.
Bioorganic & Medicinal Chemistry|January 29, 2014
Synthesis and biological evaluation of benzo[4,5]imidazo[1,2-c]pyrimidine and benzo[4,5]imidazo[1,2-a]pyrazine derivatives as anaplastic lymphoma kinase inhibitorsSébastien Tardy, Alexandre Orsato, Luca Mologni, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 9, 2009
Alpha-keto acid metabolites of naturally occurring organoselenium compounds as inhibitors of histone deacetylase in human prostate cancer cellsJeong-In Lee, Hui Nian, Arthur J L Cooper, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 11, 2017
Mechanistic Investigations Into the Developmental Toxicity of Nitrated and Heterocyclic PAHsAnna C Chlebowski, Gloria R Garcia, Jane K La Du, et al.
Molecular Biology and Evolution|August 4, 2016
Divergent Ah Receptor Ligand Selectivity during Hominin EvolutionTroy D Hubbard, Iain A Murray, William H Bisson, et al.
Scientific Reports|August 4, 2015
Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indolesTroy D Hubbard, Iain A Murray, William H Bisson, et al.
Journal of Medicinal Chemistry|September 2, 2009
Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligandsWilliam H Bisson, Daniel C Koch, Edmond F O'Donnell, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Current Topics in Medicinal Chemistry|August 26, 2015
Histone and Non-Histone Targets of Dietary Deacetylase InhibitorsEunah Kim, William H Bisson, Christiane V Löhr, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 17, 2025
Rethinking the Microenvironment's Role in Chemical-Induced MalignancyWilliam H Bisson, Richard A Currie, Emilia L Lim, et al.
Plos One|January 14, 2012
AHR2 mutant reveals functional diversity of aryl hydrocarbon receptors in zebrafishBritton C Goodale, Jane K La Du, William H Bisson, et al.
Biology|October 21, 2014
A Structural Switch between Agonist and Antagonist Bound Conformations for a Ligand-Optimized Model of the Human Aryl Hydrocarbon Receptor Ligand Binding DomainArden Perkins, Jessica L Phillips, Nancy I Kerkvliet, et al.
Bioorganic & Medicinal Chemistry|January 29, 2014
Synthesis and biological evaluation of benzo[4,5]imidazo[1,2-c]pyrimidine and benzo[4,5]imidazo[1,2-a]pyrazine derivatives as anaplastic lymphoma kinase inhibitorsSébastien Tardy, Alexandre Orsato, Luca Mologni, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 9, 2009
Alpha-keto acid metabolites of naturally occurring organoselenium compounds as inhibitors of histone deacetylase in human prostate cancer cellsJeong-In Lee, Hui Nian, Arthur J L Cooper, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 11, 2017
Mechanistic Investigations Into the Developmental Toxicity of Nitrated and Heterocyclic PAHsAnna C Chlebowski, Gloria R Garcia, Jane K La Du, et al.
Molecular Biology and Evolution|August 4, 2016
Divergent Ah Receptor Ligand Selectivity during Hominin EvolutionTroy D Hubbard, Iain A Murray, William H Bisson, et al.
Scientific Reports|August 4, 2015
Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indolesTroy D Hubbard, Iain A Murray, William H Bisson, et al.
Journal of Medicinal Chemistry|September 2, 2009
Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligandsWilliam H Bisson, Daniel C Koch, Edmond F O'Donnell, et al.
Pageof 7